|
Roflumilast 500 Mcg Oral Tablet Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Early 1: 1
Top Sponsors
- University of Arizona1
Indications
- Cell Therapy1
- Donor Lymphocyte Infusion1
- Hematopoetic Stem Cell Transplantation1
- CAR T Cell Therapy1
- Leukemia1
Tucson, Arizona1 trial
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
The University of Arizona
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.